Actemra 162mg/0,9ml (Tocilizumab) 162mg

Actemra 162mg/0.9ml contains tocilizumab, a medication used for immune system regulation. This pre-filled syringe supports treatment for inflammatory conditions. Ideal for subcutaneous injection, it offers targeted therapy with precise dosing. Suitable for adults and certain pediatric patients.

Strength

162mg

Manufacturer / TM Owner

Roche Pharma Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tocilizumab, the active ingredient in Actemra 162mg/0.9ml, is primarily used to treat moderate to severe rheumatoid arthritis in adults. It is also prescribed for giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis. This medication helps reduce inflammation and joint damage by targeting specific pathways in the immune system.

Side Effects

Actemra 162mg/0.9ml works by blocking interleukin-6 receptors, which play a key role in inflammation. Users may experience reduced joint pain, swelling, and stiffness over time. Some patients report improved mobility and daily functioning as inflammation decreases. Effects vary by individual and condition being treated.

Precautions & Warnings

Store Actemra 162mg/0.9ml in the refrigerator between 2°C and 8°C. Protect from light and avoid freezing. Keep out of reach of children. Do not use if the syringe is damaged or the liquid is discolored. Always follow healthcare provider instructions for safe handling and disposal.

Avoid Interactions

Actemra 162mg/0.9ml may interact with other medications that affect the immune system, such as corticosteroids or biologics. Combining it with live vaccines is not recommended due to potential risks. Inform your doctor about all prescription, over-the-counter, and herbal products you use. Alcohol and certain supplements may also interact.

Frequently Asked Questions

Actemra 162mg/0.9ml is used to treat inflammatory conditions like rheumatoid arthritis, giant cell arteritis, and juvenile idiopathic arthritis.

It is administered as a subcutaneous injection, typically under the skin of the thigh or abdomen, following healthcare provider guidance.

Actemra 162mg/0.9ml is available by prescription; consult a healthcare provider for appropriate sourcing options.

Common effects may include injection site reactions, upper respiratory infections, or headaches. Report persistent issues to a healthcare professional.

Safety during pregnancy has not been established; discuss risks and benefits with a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.